Dysplastic naevi: an update
- PMID: 20055909
- DOI: 10.1111/j.1365-2559.2009.03450.x
Dysplastic naevi: an update
Abstract
Dysplastic naevi are clinically atypical and histologically are characterized by architectural disorder and cytological atypia. Their diagnosis is reproducible if criteria and thresholds are agreed upon. They are significant only in relation to melanoma, as simulants of melanoma, as markers of individuals at increased risk of developing melanoma, and as potential and occasional actual precursors of melanoma. Morphologically and biologically, they are intermediate between common naevi and melanoma. Individuals with dysplastic naevi may have deficient DNA repair, and dysplastic naevi lesions are associated with overexpression of pheomelanin, which may lead to increased oxidative damage and increased potential for DNA damage and tumour progression.
Comment in
-
Dysplastic naevi, again.Histopathology. 2010 Aug;57(2):317; author reply 317-8. doi: 10.1111/j.1365-2559.2010.03604.x. Histopathology. 2010. PMID: 20716173 No abstract available.
Similar articles
-
Dysplastic naevi, again.Histopathology. 2010 Aug;57(2):317; author reply 317-8. doi: 10.1111/j.1365-2559.2010.03604.x. Histopathology. 2010. PMID: 20716173 No abstract available.
-
Melanoma progression.Pathology. 2016 Feb;48(2):147-54. doi: 10.1016/j.pathol.2015.12.002. Epub 2016 Jan 16. Pathology. 2016. PMID: 27020387
-
[Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra].Ned Tijdschr Geneeskd. 1997 Oct 18;141(42):2010-4. Ned Tijdschr Geneeskd. 1997. PMID: 9550752 Dutch.
-
Common and uncommon variants of melanocytic naevi.Pathology. 2004 Oct;36(5):396-403. doi: 10.1080/00313020412331283888. Pathology. 2004. PMID: 15370108 Review.
-
The approach to the patient with a difficult melanocytic lesion.Pathology. 2004 Oct;36(5):428-34. doi: 10.1080/00313020412331283905. Pathology. 2004. PMID: 15370112 Review.
Cited by
-
Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.J Invest Dermatol. 2014 Dec;134(12):2957-2966. doi: 10.1038/jid.2014.270. Epub 2014 Jul 7. J Invest Dermatol. 2014. PMID: 24999589
-
[Dysplastic melanocytic nevus].Pathologe. 2015 Feb;36(1):46-50, 52. doi: 10.1007/s00292-014-2061-5. Pathologe. 2015. PMID: 25591417 Review. German.
-
Texture Analysis in Diagnosing Skin Pigmented Lesions in Normal and Polarized Light-A Preliminary Report.J Clin Med. 2022 Apr 29;11(9):2505. doi: 10.3390/jcm11092505. J Clin Med. 2022. PMID: 35566634 Free PMC article.
-
Massively parallel sequencing analysis of benign melanocytic naevi.Histopathology. 2019 Jul;75(1):29-38. doi: 10.1111/his.13843. Epub 2019 May 24. Histopathology. 2019. PMID: 30791119 Free PMC article.
-
Predictive Nuclear Chromatin Characteristics of Melanoma and Dysplastic Nevi.J Pathol Inform. 2017 Apr 10;8:15. doi: 10.4103/jpi.jpi_84_16. eCollection 2017. J Pathol Inform. 2017. PMID: 28480118 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical